文献速递前列腺癌前列腺增生与排尿功能障碍

前列腺癌放疗与尿道狭窄:系统综述与荟萃分析

Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2018-01-02

单纯EBRT后为1.5%,单纯BT后为1.9%,EBRT联合BT后为4.9%。联合EBRT与BT较单纯EBRT使狭窄诊断比例估计差值增加3%(95%CI 1-6%),p=0.018。

要点

  • 前列腺癌放疗后尿道狭窄合并患病率为2.2%(95%CI 1.9-2.6%),中位随访4年。
  • EBRT联合BT后狭窄患病率为4.9%,高于单纯EBRT的1.5%和单纯BT的1.9%。
  • 联合EBRT与BT较单纯EBRT使狭窄诊断比例估计差值增加3%(95%CI 1-6%),p=0.018。

核心结论

  • 短期随访下,接受放疗的前列腺癌患者中2.2%发生尿道狭窄。
  • 接受EBRT联合BT增加狭窄形成风险。
  • 需要更长随访以确定放疗后狭窄形成的长期自然史。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed/Medline、Cochrane和Embase数据库2000年1月至2016年4月发表的文献。
  • 纳入标准为报告以EBRT、BT或两者作为前列腺癌主要治疗后尿道狭窄患病率的任何研究。

主要发现

  • 共16129例前列腺癌患者接受EBRT(5681例,35.2%)、BT(5849例,36.3%)或两者(4599例,28.5%)。
  • 随访期间共诊断630例狭窄,中位随访4年(IQR 2.7-5),汇总估计期间患病率为2.2%(95%CI 1.9-2.6%)。
  • EBRT后汇总估计患病率为1.5%(95%CI 0.9-2%),BT后为1.9%(95%CI 1.3-2.4%),EBRT联合BT后为4.9%(95%CI 3.8-6%)。
  • 20项研究报告狭窄形成中位时间,总体中位时间为2.2年(IQR 1.8-2.5,范围1.4-9)。
  • 荟萃回归分析中,与单纯EBRT相比,接受EBRT联合BT使狭窄诊断比例的估计差值增加3%(95%CI 1-6%),p=0.018;中位随访时间增加显著增加尿道狭窄发生风险(p=0.04)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We performed a systematic review and meta-analysis to determine the prevalence and predictors of urethral stricture development post radiation therapy (RT) for prostate cancer (PCa). METHODS: Published articles in PubMed/Medline, Cochrane, and Embase databases from January 2000 to April 2016 were queried. Inclusion criteria were any study that reported the prevalence of urethral strictures following external beam radiation therapy (EBRT), brachytherapy (BT), or both as a primary treatment for PCa. Forty-six articles met our inclusion criteria. A summary estimate of the proportion of patients who developed a urethral stricture was derived via a random effects meta-analysis. RESULTS: In total, 16,129 PCa patients underwent either EBRT (5681, 35.2%), BT (5849, 36.3%), or both (4599, 28.5%). Overall, 630 strictures were diagnosed at follow-up with a pooled estimate period prevalence of 2.2% (95% confidence interval, CI 1.9-2.6%) in a median follow-up time of 4 years (interquartile range, IQR 2.7-5). Of which, the pooled estimate prevalence was 1.5% (95% CI 0.9-2%) post EBRT, 1.9% (95% CI 1.3-2.4%) post BT, and 4.9% (95% CI 3.8-6%) post both EBRT and BT. Of 20 studies reporting a median time to stricture formation, the overall median time was 2.2 years (IQR 1.8-2.5, range 1.4-9). In a meta-regression analysis, receiving both EBRT and BT increased the estimated difference in proportion of stricture diagnoses by 3% (95% CI 1-6%), p = 0.018 compared to EBRT alone. An increase in median follow-up time was found to significantly increase the risk of developing urethral strictures (p = 0.04). CONCLUSIONS: With a short-term follow-up, urethral strictures occur in 2.2% of men with PCa receiving radiotherapy. Receiving both EBRT and BT increased the risk of stricture formation. Longer follow-up is needed to determine the long-term natural history of stricture formation after RT.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Awad MA, Gaither TW, Osterberg EC, et al. Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2018. PMID: 29296018. doi:10.1038/s41391-017-0028-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。